[Hsa_circ_0005221 promotes prostate cancer progression through the miR-339-5p/STAT5a pathway]

Sai-Sai Chen1, Yu-Wei Zhang2, Ya-Li Wang3

  • 1Research Institute of Urology, Southeast University School of Medicine, Nanjing, Jiangsu 211189, China.

Insights

Hsa_circ_0005221 promotes prostate cancer (PCa) progression by regulating the miR-339-5p/STAT5a pathway. This circular RNA enhances PCa cell proliferation, invasion, and migration while suppressing apoptosis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Prostate cancer (PCa) remains a significant health concern.
  • Understanding the molecular mechanisms driving PCa progression is crucial for developing effective therapies.
  • Circular RNAs (circRNAs) have emerged as key regulators in various cancers, including PCa.

Purpose of the Study:

  • To elucidate the role of hsa_circ_0005221 in PCa progression.
  • To investigate the molecular pathway involving hsa_circ_0005221, miR-339-5p, and STAT5a in PCa.
  • To determine the therapeutic potential of targeting this pathway.

Main Methods:

  • Quantitative real-time PCR (qPCR) to assess gene expression.
  • Nuclear-cytoplasmic isolation to determine cellular localization.
  • RNA pull-down and luciferase reporter assays to confirm molecular interactions.
  • Cell transfection with plasmids and siRNAs to manipulate gene expression and assess functional changes (proliferation, invasion, migration, apoptosis, epithelial-mesenchymal transition).

Main Results:

  • Hsa_circ_0005221 expression is significantly upregulated in PCa tissues and cells.
  • Hsa_circ_0005221 and miR-339-5p are primarily located in the cytoplasm.
  • Hsa_circ_0005221 promotes PCa cell proliferation, invasion, migration, and epithelial-mesenchymal transition (EMT) while inhibiting apoptosis.
  • Hsa_circ_0005221 directly binds to miR-339-5p, and this interaction influences STAT5a expression.
  • Knockdown of hsa_circ_0005221 or overexpression of miR-339-5p reversed the pro-cancerous effects.

Conclusions:

  • Hsa_circ_0005221 acts as an oncogenic circRNA in PCa.
  • The hsa_circ_0005221/miR-339-5p/STAT5a axis is a critical pathway driving PCa progression.
  • Targeting hsa_circ_0005221 may represent a novel therapeutic strategy for PCa.
Abstract

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.5K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.7K